T1	Participants 63 89	chronic alcoholic patients
T2	Participants 194 323	32 randomly selected hospitalized male alcoholic patients with clinical, biochemical and histological evidence of hepatic damage.
T3	Participants 1222 1264	patients with alcoholic liver disease (ALD